Dan Weng
President chez EPS International Co. Ltd.
Profil
Dan Weng is currently the President & Representative Director at EPS International Co. Ltd., EPS Global Research, Inc., EPS International (Korea) Ltd., and Ever Progressing System (Hong Kong) Ltd.
He previously served as the Chief Executive Officer & Director at Ergomed Plc in 2017, and as the Director & Senior Executive Officer at EPS Holdings, Inc. from 2013 to 2016.
He also held a Vice President position at Medpace, Inc. Dr. Weng graduated from the University of Leeds with a graduate degree, the University of Strathclyde with a doctorate degree, and Tongji Medical College of Huazhong University of Sci & Tech with a doctorate degree.
Postes actifs de Dan Weng
| Sociétés | Poste | Début |
|---|---|---|
EPS International Co. Ltd.
 EPS International Co. Ltd. Miscellaneous Commercial ServicesCommercial Services EPS International Co. Ltd. a subsidiary of a public listed company EPS Co. Ltd in Tokyo, Japan, commences its business operations in April 2007. The company aims to provide a seamless clinical research and development platform through strategizing and synergizing its established research networks, valuable knowledge, know-how, resources and experiences in Asia region. The company manages large- and small-scale, global and local clinical trials covering from first-in-man to post marketing surveillance for new chemical entities, biologics and medical devices. | President | 01/12/2013 |
| EPS International (Korea) Ltd. | Directeur/Membre du Conseil | 01/06/2012 |
EPS Global Research, Inc.
 EPS Global Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of EPS Holdings, Inc., EPS Global Research, Inc. operates clinical trials. | President | 01/06/2014 |
| Ever Progressing System (Hong Kong) Ltd. | Directeur/Membre du Conseil | 01/03/2012 |
Anciens postes connus de Dan Weng
| Sociétés | Poste | Fin |
|---|---|---|
| ERGOMED | Directeur Général | 15/12/2017 |
| EPS HOLDINGS, INC. | Directeur/Membre du Conseil | 22/12/2016 |
Medpace, Inc.
 Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Medpace, Inc. provides clinical research services to the pharmaceutical, biotech and medical industries. It offers clinical operations, medical writing, biometrics, regulatory affairs, quality assurance, imaging core lab medical device and risk based monitoring services. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH. | Corporate Officer/Principal | - |
Formation de Dan Weng
| University of Leeds | Graduate Degree |
| University of Strathclyde | Doctorate Degree |
| Tongji Medical College of Huazhong University of Sci & Tech | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ERGOMED | Commercial Services |
| Entreprise privées | 6 |
|---|---|
Medpace, Inc.
Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Medpace, Inc. provides clinical research services to the pharmaceutical, biotech and medical industries. It offers clinical operations, medical writing, biometrics, regulatory affairs, quality assurance, imaging core lab medical device and risk based monitoring services. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH. | Commercial Services |
EPS Holdings, Inc.
 EPS Holdings, Inc. BiotechnologyHealth Technology EPS Holdings, Inc. engages in the drug development business. It operates through the following segments: Contract Research Organization (CRO), Site Management Organization (SMO), Contract Sales Organization (CSO), Global Research, Ekishin, and Others. The CRO segment offers clinical trials, data management, and statistical analysis. The SMO segment enters into contracts with medical institutions to conduct clinical trials. The CSO segment provides drug information and awareness for medical and pharmaceutical industries. The Global Research segment provides consignment services through its subsidiary for multilateral clinical trials in Asia-Pacific. The Ekishin segment focuses on medical equipment, pharmaceutical and investment related businesses through its Japan and China based subsidiaries. The Others segment provides various services related to management of clinical research from business processing outsource business related to medicine and medical care. The company was founded on May 30, 1991 and is headquartered in Tokyo, Japan. | Health Technology |
EPS International Co. Ltd.
EPS International Co. Ltd. Miscellaneous Commercial ServicesCommercial Services EPS International Co. Ltd. a subsidiary of a public listed company EPS Co. Ltd in Tokyo, Japan, commences its business operations in April 2007. The company aims to provide a seamless clinical research and development platform through strategizing and synergizing its established research networks, valuable knowledge, know-how, resources and experiences in Asia region. The company manages large- and small-scale, global and local clinical trials covering from first-in-man to post marketing surveillance for new chemical entities, biologics and medical devices. | Commercial Services |
| EPS International (Korea) Ltd. | |
EPS Global Research, Inc.
EPS Global Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of EPS Holdings, Inc., EPS Global Research, Inc. operates clinical trials. | Commercial Services |
| Ever Progressing System (Hong Kong) Ltd. | Miscellaneous |
